chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis contact
Clinical narrative: Patient got into poison ivy; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (Patient got into poison ivy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and FINASTERIDE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced DERMATITIS CONTACT (Patient got into poison ivy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DERMATITIS CONTACT (Patient got into poison ivy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Nausea, Pain in extremity, Vaccination site erythema
Clinical narrative: Hot at injection site; Red at injection site; Rash at injection site that was about 4 inches circular oval; Itching at injection site; Super sore arm; Migraine; Lightheaded/dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Super sore arm), MIGRAINE (Migraine), DIZZINESS (Lightheaded/dizzy), VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE PRURITUS (Itching at injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0251921A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Depression. Previously administered products included for an unreported indication: SHINGRIX (Hot and red at vaccination site.). Concurrent medical conditions included Vitamin D deficiency (Low vitamin D.) and Drug allergy (Allergic to sulfa and gabapentin.). Concomitant products included ESCITALOPRAM from 09-Jan-2020 to 13-Apr-2021 for Depression, VITAMIN D NOS for Vitamin D deficiency.   On 12-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Super sore arm), MIGRAINE (Migraine), DIZZINESS (Lightheaded/dizzy) and NAUSEA (Nauseous). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site). On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at injection site that was about 4 inches circular oval). On 12-Mar-2021, DIZZINESS (Lightheaded/dizzy) and NAUSEA (Nauseous) had resolved. On 13-Mar-2021, MIGRAINE (Migraine) had resolved. On 16-Mar-2021, PAIN IN EXTREMITY (Super sore arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at injection site that was about 4 inches circular oval) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable. Treatment information includes ondansetron 7mg one dose for vomiting    Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11 May 2021 and contains patient demographic details were updated, Other relevant history was updated,  concomitant medications were added, event outcomes were updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Hot at injection site; Red at injection site; Rash at injection site that was about 4 inches circular oval; Itching at injection site; Super sore arm; Migraine; Lightheaded/dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Super sore arm), MIGRAINE (Migraine), DIZZINESS (Lightheaded/dizzy), VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE PRURITUS (Itching at injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0251921A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Depression. Previously administered products included for an unreported indication: SHINGRIX (Hot and red at vaccination site.). Concurrent medical conditions included Vitamin D deficiency (Low vitamin D.) and Drug allergy (Allergic to sulfa and gabapentin.). Concomitant products included ESCITALOPRAM from 09-Jan-2020 to 13-Apr-2021 for Depression, VITAMIN D NOS for Vitamin D deficiency.   On 12-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Super sore arm), MIGRAINE (Migraine), DIZZINESS (Lightheaded/dizzy) and NAUSEA (Nauseous). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site). On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at injection site that was about 4 inches circular oval). On 12-Mar-2021, DIZZINESS (Lightheaded/dizzy) and NAUSEA (Nauseous) had resolved. On 13-Mar-2021, MIGRAINE (Migraine) had resolved. On 16-Mar-2021, PAIN IN EXTREMITY (Super sore arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at injection site that was about 4 inches circular oval) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable. Treatment information includes ondansetron 7mg one dose for vomiting    Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11 May 2021 and contains patient demographic details were updated, Other relevant history was updated,  concomitant medications were added, event outcomes were updated.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Chills, Cough, Depressed mood, Headache
Clinical narrative: fever; headache; everything; miserable; flu-like symptoms; dry cough; chills; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough), CHILLS (chills) and HEADACHE (headache). On an unknown date, the patient experienced PYREXIA (fever). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: fever; headache; everything; miserable; flu-like symptoms; dry cough; chills; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough), CHILLS (chills) and HEADACHE (headache). On an unknown date, the patient experienced PYREXIA (fever). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (everything), DEPRESSED MOOD (miserable), INFLUENZA LIKE ILLNESS (flu-like symptoms), COUGH (dry cough), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Reaction to excipient
Clinical narrative: eye problem; Reaction to sucrose in vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (eye problem) and REACTION TO EXCIPIENT (Reaction to sucrose in vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (eye problem) and REACTION TO EXCIPIENT (Reaction to sucrose in vaccine). At the time of the report, EYE DISORDER (eye problem) had resolved and REACTION TO EXCIPIENT (Reaction to sucrose in vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were vinegar and vitamin C tablets reported by the reporter.  No concomitant medication reported   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Pruritus, Pyrexia
Clinical narrative: joint pain; Itchy skin on scalp and all over the body; Brain fog; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain), PRURITUS (Itchy skin on scalp and all over the body), FEELING ABNORMAL (Brain fog), HEADACHE (headache) and PYREXIA (fever) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRALGIA (joint pain), PRURITUS (Itchy skin on scalp and all over the body), FEELING ABNORMAL (Brain fog), HEADACHE (headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (joint pain), PRURITUS (Itchy skin on scalp and all over the body), FEELING ABNORMAL (Brain fog), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Fatigue, Myalgia
Clinical narrative: Pregnant and received both the doses of vaccine; Fatigue which left for around 8 hours; body ache; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine), FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sinus tachycardia in 2015, Polycystic ovarian syndrome in 2015, Obesity in 2015 and Vitamin D deficiency in 2015. Family history included Hypertension since an unknown date, Hypertension (Father's history), Diabetes (Father and Mother's History), Hyperlipidemia (Father's History), Gout (Father's History) and Hashimoto's disease (Mother's History). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], METFORMIN, METOPROLOL and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 16-Dec-2020 and the estimated date of delivery was 29-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine), FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine) had resolved and FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Product also includes: Prenatal Fish Oil  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain, Fatigue
Clinical narrative: lump under her armpit in the same arm of injection; some soreness under her armpit; armpit feels uncomfortable; tired; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (lump under her armpit in the same arm of injection), AXILLARY PAIN (some soreness under her armpit), AXILLARY PAIN (armpit feels uncomfortable) and FATIGUE (tired) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced AXILLARY PAIN (armpit feels uncomfortable) and FATIGUE (tired). On 24-Mar-2021, the patient experienced AXILLARY PAIN (some soreness under her armpit). On 25-Mar-2021, the patient experienced AXILLARY MASS (lump under her armpit in the same arm of injection). At the time of the report, AXILLARY MASS (lump under her armpit in the same arm of injection), AXILLARY PAIN (some soreness under her armpit), AXILLARY PAIN (armpit feels uncomfortable) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment details include half a Mobic pill   This case was linked to MOD-2021-121332 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Red; Itchy; Rashy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE RASH (Rashy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE RASH (Rashy). At the time of the report, VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE RASH (Rashy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided    Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: NNI
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Nausea, Pain in extremity, Vaccination site erythema
Clinical narrative: Lightheaded and dizzy; I had a migraine for 2 days; Nauseous the first night; First 4 days, my arm was super sore I couldn't sleep on it; 12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval; It started itching a few days ago but there wasn't anything there; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it), MIGRAINE (I had a migraine for 2 days), DIZZINESS (Lightheaded and dizzy) and VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it), MIGRAINE (I had a migraine for 2 days), DIZZINESS (Lightheaded and dizzy) and NAUSEA (Nauseous the first night). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there). On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), VACCINATION SITE ERYTHEMA (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) and VACCINATION SITE RASH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval). On 12-Mar-2021, DIZZINESS (Lightheaded and dizzy) and NAUSEA (Nauseous the first night) had resolved. On 13-Mar-2021, MIGRAINE (I had a migraine for 2 days) had resolved. On 16-Mar-2021, PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it) had resolved. At the time of the report, VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there), VACCINATION SITE ERYTHEMA (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) and VACCINATION SITE RASH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Lightheaded and dizzy; I had a migraine for 2 days; Nauseous the first night; First 4 days, my arm was super sore I couldn't sleep on it; 12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval; It started itching a few days ago but there wasn't anything there; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it), MIGRAINE (I had a migraine for 2 days), DIZZINESS (Lightheaded and dizzy) and VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it), MIGRAINE (I had a migraine for 2 days), DIZZINESS (Lightheaded and dizzy) and NAUSEA (Nauseous the first night). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there). On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), VACCINATION SITE ERYTHEMA (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) and VACCINATION SITE RASH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval). On 12-Mar-2021, DIZZINESS (Lightheaded and dizzy) and NAUSEA (Nauseous the first night) had resolved. On 13-Mar-2021, MIGRAINE (I had a migraine for 2 days) had resolved. On 16-Mar-2021, PAIN IN EXTREMITY (First 4 days, my arm was super sore I couldn't sleep on it) had resolved. At the time of the report, VACCINATION SITE WARMTH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval), VACCINATION SITE PRURITUS (It started itching a few days ago but there wasn't anything there), VACCINATION SITE ERYTHEMA (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) and VACCINATION SITE RASH (12 days after vaccine my arm got a rash and hot and red at the site about 4 inches circular oval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Bladder pain, Body temperature, Decreased appetite, Dizziness
Clinical narrative: itchy; dizzy; stiff neck; watery eyes; no appetite; pain in ovaries or bladder; pain in ovaries or bladder; breathlessness; feels slightly frightened; headache/ back of head hurts/ got worse; feels aches all over body including hands/hurts in between shoulder blades; fever ranging from 101,102 to 104 degrees Fahrenheit; nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes) and DECREASED APPETITE (no appetite) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 101 °F (High) 101, 102 °F (High) 102 and 104 °F (High) 104.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fear, Headache, Lacrimation increased, Musculoskeletal stiffness
Clinical narrative: itchy; dizzy; stiff neck; watery eyes; no appetite; pain in ovaries or bladder; pain in ovaries or bladder; breathlessness; feels slightly frightened; headache/ back of head hurts/ got worse; feels aches all over body including hands/hurts in between shoulder blades; fever ranging from 101,102 to 104 degrees Fahrenheit; nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes) and DECREASED APPETITE (no appetite) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 101 °F (High) 101, 102 °F (High) 102 and 104 °F (High) 104.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pruritus, Pyrexia
Clinical narrative: itchy; dizzy; stiff neck; watery eyes; no appetite; pain in ovaries or bladder; pain in ovaries or bladder; breathlessness; feels slightly frightened; headache/ back of head hurts/ got worse; feels aches all over body including hands/hurts in between shoulder blades; fever ranging from 101,102 to 104 degrees Fahrenheit; nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes) and DECREASED APPETITE (no appetite) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 101 °F (High) 101, 102 °F (High) 102 and 104 °F (High) 104.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site rash
Clinical narrative: Red rash; Red rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash) and VACCINATION SITE RASH (Red rash on injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 031620A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red rash) and VACCINATION SITE RASH (Red rash on injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Red rash) and VACCINATION SITE RASH (Red rash on injection site) had resolved.     No concomitant medication was reported.  The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Event outcome was updated to resolved.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Decreased appetite, Fatigue, Lethargy
Clinical narrative: COVID positive 2-3 days after the shot; Feeling lethargic; Didn't have much of an appetite; pain; Just wanted to sit all the time; chills; vomitting; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), DECREASED APPETITE (Didn't have much of an appetite), PAIN (pain) and FATIGUE (Just wanted to sit all the time) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), DECREASED APPETITE (Didn't have much of an appetite), PAIN (pain), FATIGUE (Just wanted to sit all the time), CHILLS (chills) and VOMITING (vomitting). At the time of the report, COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), PAIN (pain), FATIGUE (Just wanted to sit all the time), CHILLS (chills) and VOMITING (vomitting) outcome was unknown and DECREASED APPETITE (Didn't have much of an appetite) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided   This case was linked to MOD-2021-057946, MOD-2021-039604 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: COVID positive 2-3 days after the shot; Feeling lethargic; Didn't have much of an appetite; pain; Just wanted to sit all the time; chills; vomitting; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), DECREASED APPETITE (Didn't have much of an appetite), PAIN (pain) and FATIGUE (Just wanted to sit all the time) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), DECREASED APPETITE (Didn't have much of an appetite), PAIN (pain), FATIGUE (Just wanted to sit all the time), CHILLS (chills) and VOMITING (vomitting). At the time of the report, COVID-19 (COVID positive 2-3 days after the shot), LETHARGY (Feeling lethargic), PAIN (pain), FATIGUE (Just wanted to sit all the time), CHILLS (chills) and VOMITING (vomitting) outcome was unknown and DECREASED APPETITE (Didn't have much of an appetite) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided   This case was linked to MOD-2021-057946, MOD-2021-039604 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, COVID-19, Dyspnoea
Clinical narrative: tested positive for COVID-19; Loss of taste; Loss of smell; difficulty breathing; aching all over; joint pain; very fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing) and MYALGIA (aching all over) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient did not have any medical history.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain), FATIGUE (very fatigue) and PYREXIA (fever). On 24-Mar-2021, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain) and PYREXIA (fever) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown and FATIGUE (very fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. No treatment information was provided. It was reported that the patient still felt tired at the time of report. The patient was scheduled for second dose on 03-Apr-2021.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: tested positive for COVID-19; Loss of taste; Loss of smell; difficulty breathing; aching all over; joint pain; very fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing) and MYALGIA (aching all over) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient did not have any medical history.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain), FATIGUE (very fatigue) and PYREXIA (fever). On 24-Mar-2021, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain) and PYREXIA (fever) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown and FATIGUE (very fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. No treatment information was provided. It was reported that the patient still felt tired at the time of report. The patient was scheduled for second dose on 03-Apr-2021.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: left side of her face around the cheekbone feels like it is kind of numbing and tingling; left side of her face around the cheekbone feels like it is kind of numbing and tingling; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling). At the time of the report, HYPOAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) and PARAESTHESIA (left side of her face around the cheekbone feels like it is kind of numbing and tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medication include allergy meds  No treatment information was provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Nasopharyngitis, Pyrexia, Vaccination site pain
Clinical narrative: Feeling Strange; feel like cold is coming; fever; tenderness at injection spot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling Strange), NASOPHARYNGITIS (feel like cold is coming), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness at injection spot) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling Strange), NASOPHARYNGITIS (feel like cold is coming), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness at injection spot). At the time of the report, FEELING ABNORMAL (Feeling Strange), NASOPHARYNGITIS (feel like cold is coming), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness at injection spot) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 100 degree (High) 100 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: NNI FU
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced MYALGIA (Body aches). At the time of the report, MYALGIA (Body aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up received on 12-May-2021, contains no new information.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Experienced diarrhea; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Experienced diarrhea) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DIARRHOEA (Experienced diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Experienced diarrhea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: NNI
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Limb discomfort, Malaise, Movement disorder
Clinical narrative: being sick; chills; feeling really bad fatigue; I can't sit for more than 15 minutes"; lifting arm is challenging; arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (I can't sit for more than 15 minutes"), MALAISE (being sick), VACCINATION SITE PAIN (arm is sore), CHILLS (chills) and FATIGUE (feeling really bad fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm is sore) and LIMB DISCOMFORT (lifting arm is challenging). On 25-Mar-2021, the patient experienced MOVEMENT DISORDER (I can't sit for more than 15 minutes"), CHILLS (chills) and FATIGUE (feeling really bad fatigue). On an unknown date, the patient experienced MALAISE (being sick). At the time of the report, MOVEMENT DISORDER (I can't sit for more than 15 minutes"), MALAISE (being sick), VACCINATION SITE PAIN (arm is sore), CHILLS (chills), FATIGUE (feeling really bad fatigue) and LIMB DISCOMFORT (lifting arm is challenging) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided